Skip to main content
. 2020 Aug 6;6(2):e001350. doi: 10.1136/rmdopen-2020-001350

Table 1.

Laboratory findings of clinical course

On admission
(day 1)
Before intubation
(day 3)
Before extubation
(day 12)
After improvement of pneumonia
(day 18)
When arthritis develops
(day 22)
After improvement
of arthritis
(day 52)
WBC (cells/mm3, 3300–8600) 3600 2900 5400 5300 9300 5200
Neutrophil (%) 74 76.5 85 70.5 71.5 68.6
Lymphocyte (%) 18 18.5 7.5 19 15 21.8
Eosinophil (%) 0 0 0.5 1 0.5 1.1
Monocyte (%) 8 4.5 6.5 8.5 12 7.4
Basophil (%) 0 0 0 0 1 1.1
Atypical lymphocyte (%) 0 0.5 0.5 1 0 0
Haemoglobin (g/L, 137–168) 161 145 119 124 118 116
Platelet (×104/μL, 15.8–34.8) 12.3 13.3 32.9 29.1 33.1 26.8
BUN (mg/dL, 8.0–20.0) 17 14.7 24.1 13.3 12.7 11.8
Creatinine (mg/dL, 0.65–1.07) 1.85 1.22 1.79 1.42 1.38 1.26
Uric acid (mg/dL, 3.7–7.8) 3.8 5.1 5.2 7.2
AST (IU/L, 13–30) 118 112 112 80 119 19
CK (IU/L, 59–248) 98 184 49 53
LDH (IU/L, 124–222) 398 468 316 361 339 166
Bilirubin (mg/dL, 0.4–1.5) 0.9 1.6 0.8 1.2 0.5
CRP (mg/dL, 0.00–0.14) 8.31 9.45 14.15 1.62 7.4 0.88
D-dimer (μg/mL, 0.0–1.0) 2.2 12.8 7.2 3.6 1.9
Procalcitonin (ng/mL, 0.0–0.50) 0.27

WBC, white blood cell; BUN, blood urea nitrogen; AST, aspartate transaminase; CK, creatine kinase; LDH, lactic dehydrogenase.

HHS Vulnerability Disclosure